OptumRx Reaches $20M Settlement Agreement For Opioid Prescription Practices
WASHINGTON, D.C. — OptumRx Inc. has agreed to pay $20 million to resolve claims that the prescription drug benefit provider improperly filled opioid prescriptions in violation of the Controlled Substances Act,...To view the full article, register now.
Already a subscriber? Click here to view full article